scholarly journals 1330: Brigatinib efficacy and safety in patients (Pts) with anaplastic lymphoma kinase (ALK)-positive (ALK+) non-small cell lung cancer (NSCLC) in a phase 1/2 trial

2016 ◽  
Vol 11 (4) ◽  
pp. S114 ◽  
Author(s):  
R. Rosell ◽  
S.N. Gettinger ◽  
L.A. Bazhenova ◽  
C.J. Langer ◽  
R. Salgia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Phase 1 ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma ◽  
Alk Positive

scholarly journals Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive advanced-stage non-small-cell lung cancer

2018 ◽  
Vol Volume 10 ◽  
pp. 6555-6561 ◽  
Author(s):  
Ahmed Mohieldin ◽  
Ayman Rasmy ◽  
Mohamed Ashour ◽  
Muath Al-Nassar ◽  
Rola H Ali ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Anaplastic Lymphoma Kinase ◽  
Small Cell ◽  
Advanced Stage ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Anaplastic Lymphoma
Sign in / Sign up

Export Citation Format

Share Document